---
figid: PMC4462002__40364_2015_38_Fig7_HTML
figtitle: Fanconi Anemia Pathway
organisms:
- Homo sapiens
- Mus musculus
- NA
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC4462002
filename: 40364_2015_38_Fig7_HTML.jpg
figlink: /pmc/articles/PMC4462002/figure/Fig7/
number: F7
caption: Fanconi Anemia Pathway. Endogenous and exogenous agent cause interstrand
  crosslink lesions (ICL). When an ICL occurs, the replication fork is stalled and
  the FA pathway is activated with the recruitment of the FA core complex (FANCA,
  B, C, E, F, G, L, and M). FANCL ubiqiuitinates the FANCD2-FANCI (ID2) complex that
  guides the nucleolytic incisions and translesion synthesis repair events by “unhooking”
  the ICL. This allows the homologous recombination repair through FANCD1/BRCA2, FANCJ/BRIP1,
  FANCN/PALB2, FANCO/RAD51C, and FANCS/BRCA1. Yellow stars highlight FA/HR repair
  molecules that have been found genetically inactivated in FA patients with medulloblastoma.
  BCCIP is a BRCA2 interacting protein which is able to induce medulloblastoma growth
  when genetically loss in concomitance with p53 deletion (See text). Readapted from
  []
papertitle: 'Characterization of medulloblastoma in Fanconi Anemia: a novel mutation
  in the BRCA2 gene and SHH molecular subgroup.'
reftext: Evelina Miele, et al. Biomark Res. 2015;3:13.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9664754
figid_alias: PMC4462002__F7
figtype: Figure
redirect_from: /figures/PMC4462002__F7
ndex: 988cd5fc-decd-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4462002__40364_2015_38_Fig7_HTML.html
  '@type': Dataset
  description: Fanconi Anemia Pathway. Endogenous and exogenous agent cause interstrand
    crosslink lesions (ICL). When an ICL occurs, the replication fork is stalled and
    the FA pathway is activated with the recruitment of the FA core complex (FANCA,
    B, C, E, F, G, L, and M). FANCL ubiqiuitinates the FANCD2-FANCI (ID2) complex
    that guides the nucleolytic incisions and translesion synthesis repair events
    by “unhooking” the ICL. This allows the homologous recombination repair through
    FANCD1/BRCA2, FANCJ/BRIP1, FANCN/PALB2, FANCO/RAD51C, and FANCS/BRCA1. Yellow
    stars highlight FA/HR repair molecules that have been found genetically inactivated
    in FA patients with medulloblastoma. BCCIP is a BRCA2 interacting protein which
    is able to induce medulloblastoma growth when genetically loss in concomitance
    with p53 deletion (See text). Readapted from []
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Brca1
  - fa
  - Id2
  - Atr
  - Mmab
  - Slx4
  - Fancm
  - Usp1
  - Fancg
  - Fancc
  - Fancb
  - Fancl
  - Ube2t
  - Palb2
  - Bccip
  - Rap1gap
  - Rasa1
  - Brca2
  - Lig1
  - Lrig1
  - Brip1
  - Fancd2
  - Fanci
  - Rad51
  - Xrcc2
  - BRCA1
  - ID2
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - SLX4
  - FANCA
  - FANCB
  - FANCC
  - BRCA2
  - FANCD2
  - FANCE
  - FANCF
  - FANCG
  - FANCI
  - BRIP1
  - FANCL
  - FANCM
  - PALB2
  - RAD51C
  - ERCC4
  - RAD51
  - UBE2T
  - XRCC2
  - USP1
  - BCCIP
  - RASA1
  - RGS6
  - LIG1
  - LRIG1
  - id2a
  - atr
  - slx4
  - fancm
  - usp1
  - ercc4
  - fancg
  - fancc
  - fancb
  - fancl
  - ube2t
  - palb2
  - bccip
  - gap43
  - brca2
  - lig1
  - brip1
  - fancd2
  - fanci
  - rad51c
  - rad51
  - aldehydes
  - Cisplatin
  - Breast cancer
  - Fanconi anemia
---
